nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—CYP2C9—brain cancer	0.475	1	CbGaD
Zafirlukast—CYP2D6—Lomustine—brain cancer	0.0493	0.13	CbGbCtD
Zafirlukast—CYP1A2—Carmustine—brain cancer	0.0488	0.129	CbGbCtD
Zafirlukast—ABCG2—Carboplatin—brain cancer	0.0417	0.11	CbGbCtD
Zafirlukast—CYP2D6—Hydroxyurea—brain cancer	0.0373	0.0987	CbGbCtD
Zafirlukast—CYP3A4—Temozolomide—brain cancer	0.0369	0.0974	CbGbCtD
Zafirlukast—ABCG2—Etoposide—brain cancer	0.0351	0.0926	CbGbCtD
Zafirlukast—PTGS1—Etoposide—brain cancer	0.0324	0.0855	CbGbCtD
Zafirlukast—CYP3A4—Lomustine—brain cancer	0.0313	0.0828	CbGbCtD
Zafirlukast—CYP2E1—Etoposide—brain cancer	0.025	0.066	CbGbCtD
Zafirlukast—CYP2C8—Etoposide—brain cancer	0.0187	0.0493	CbGbCtD
Zafirlukast—CYP1A2—Etoposide—brain cancer	0.0145	0.0382	CbGbCtD
Zafirlukast—CYP3A4—Etoposide—brain cancer	0.00757	0.02	CbGbCtD
Zafirlukast—Throat sore—Lomustine—brain cancer	0.00293	0.0307	CcSEcCtD
Zafirlukast—Oropharyngeal discomfort—Lomustine—brain cancer	0.00291	0.0304	CcSEcCtD
Zafirlukast—Hepatotoxicity—Lomustine—brain cancer	0.00274	0.0286	CcSEcCtD
Zafirlukast—Contusion—Lomustine—brain cancer	0.00242	0.0253	CcSEcCtD
Zafirlukast—Oropharyngeal pain—Lomustine—brain cancer	0.00232	0.0243	CcSEcCtD
Zafirlukast—Traumatic liver injury—Temozolomide—brain cancer	0.00218	0.0228	CcSEcCtD
Zafirlukast—Haematemesis—Procarbazine—brain cancer	0.00193	0.0202	CcSEcCtD
Zafirlukast—Haemoptysis—Procarbazine—brain cancer	0.00181	0.019	CcSEcCtD
Zafirlukast—Digestion impaired—Hydroxyurea—brain cancer	0.00155	0.0162	CcSEcCtD
Zafirlukast—Blister—Hydroxyurea—brain cancer	0.00144	0.0151	CcSEcCtD
Zafirlukast—Hepatotoxicity—Hydroxyurea—brain cancer	0.00134	0.0141	CcSEcCtD
Zafirlukast—Neuropathy—Procarbazine—brain cancer	0.00126	0.0132	CcSEcCtD
Zafirlukast—Digestion impaired—Temozolomide—brain cancer	0.00121	0.0127	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Procarbazine—brain cancer	0.00111	0.0117	CcSEcCtD
Zafirlukast—Hepatotoxicity—Carmustine—brain cancer	0.00109	0.0114	CcSEcCtD
Zafirlukast—Haemoglobin—Lomustine—brain cancer	0.00107	0.0112	CcSEcCtD
Zafirlukast—Haemorrhage—Lomustine—brain cancer	0.00106	0.0111	CcSEcCtD
Zafirlukast—Hepatotoxicity—Temozolomide—brain cancer	0.00105	0.011	CcSEcCtD
Zafirlukast—Liver injury—Temozolomide—brain cancer	0.000964	0.0101	CcSEcCtD
Zafirlukast—Accidental injury—Carmustine—brain cancer	0.000949	0.00992	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Temozolomide—brain cancer	0.000892	0.00933	CcSEcCtD
Zafirlukast—Infection—Carboplatin—brain cancer	0.000856	0.00896	CcSEcCtD
Zafirlukast—Hepatotoxicity—Etoposide—brain cancer	0.000841	0.00879	CcSEcCtD
Zafirlukast—Hepatic failure—Hydroxyurea—brain cancer	0.000839	0.00877	CcSEcCtD
Zafirlukast—Eosinophilia—Procarbazine—brain cancer	0.000833	0.00872	CcSEcCtD
Zafirlukast—Dermatitis bullous—Hydroxyurea—brain cancer	0.000789	0.00825	CcSEcCtD
Zafirlukast—Neuropathy—Carmustine—brain cancer	0.000788	0.00824	CcSEcCtD
Zafirlukast—Influenza like illness—Temozolomide—brain cancer	0.000788	0.00824	CcSEcCtD
Zafirlukast—Numbness—Etoposide—brain cancer	0.000783	0.00819	CcSEcCtD
Zafirlukast—Neuropathy—Temozolomide—brain cancer	0.000762	0.00797	CcSEcCtD
Zafirlukast—Sensory loss—Etoposide—brain cancer	0.000749	0.00784	CcSEcCtD
Zafirlukast—Infection—Lomustine—brain cancer	0.000749	0.00783	CcSEcCtD
Zafirlukast—Thrombocytopenia—Lomustine—brain cancer	0.000738	0.00772	CcSEcCtD
Zafirlukast—Pain—Carboplatin—brain cancer	0.000737	0.00771	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Procarbazine—brain cancer	0.000736	0.0077	CcSEcCtD
Zafirlukast—Jaundice—Procarbazine—brain cancer	0.000732	0.00765	CcSEcCtD
Zafirlukast—Swelling—Carmustine—brain cancer	0.000691	0.00722	CcSEcCtD
Zafirlukast—Body temperature increased—Carboplatin—brain cancer	0.000681	0.00713	CcSEcCtD
Zafirlukast—Haemoglobin—Procarbazine—brain cancer	0.000677	0.00708	CcSEcCtD
Zafirlukast—Haemorrhage—Procarbazine—brain cancer	0.000674	0.00705	CcSEcCtD
Zafirlukast—Injury—Carmustine—brain cancer	0.000663	0.00693	CcSEcCtD
Zafirlukast—Hepatic failure—Temozolomide—brain cancer	0.000655	0.00685	CcSEcCtD
Zafirlukast—Neuropathy—Etoposide—brain cancer	0.000609	0.00637	CcSEcCtD
Zafirlukast—Neutropenia—Hydroxyurea—brain cancer	0.000609	0.00637	CcSEcCtD
Zafirlukast—Body temperature increased—Lomustine—brain cancer	0.000596	0.00623	CcSEcCtD
Zafirlukast—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000581	0.0115	CbGpPWpGaD
Zafirlukast—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000569	0.00596	CcSEcCtD
Zafirlukast—Liver function test abnormal—Carmustine—brain cancer	0.000563	0.00588	CcSEcCtD
Zafirlukast—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000559	0.0111	CbGpPWpGaD
Zafirlukast—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000535	0.0106	CbGpPWpGaD
Zafirlukast—Swelling—Etoposide—brain cancer	0.000534	0.00559	CcSEcCtD
Zafirlukast—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000526	0.0104	CbGpPWpGaD
Zafirlukast—Haemoglobin—Hydroxyurea—brain cancer	0.000524	0.00548	CcSEcCtD
Zafirlukast—Haemorrhage—Hydroxyurea—brain cancer	0.000521	0.00545	CcSEcCtD
Zafirlukast—Glyburide—CYP2C9—brain cancer	0.000518	1	CrCbGaD
Zafirlukast—Arthralgia—Procarbazine—brain cancer	0.000499	0.00522	CcSEcCtD
Zafirlukast—Myalgia—Procarbazine—brain cancer	0.000499	0.00522	CcSEcCtD
Zafirlukast—Neutropenia—Carmustine—brain cancer	0.000492	0.00515	CcSEcCtD
Zafirlukast—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000492	0.00975	CbGpPWpGaD
Zafirlukast—Vomiting—Lomustine—brain cancer	0.000479	0.00501	CcSEcCtD
Zafirlukast—Oedema—Procarbazine—brain cancer	0.000479	0.00501	CcSEcCtD
Zafirlukast—Neutropenia—Temozolomide—brain cancer	0.000476	0.00498	CcSEcCtD
Zafirlukast—Infection—Procarbazine—brain cancer	0.000476	0.00497	CcSEcCtD
Zafirlukast—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000473	0.00937	CbGpPWpGaD
Zafirlukast—Thrombocytopenia—Procarbazine—brain cancer	0.000469	0.0049	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Carmustine—brain cancer	0.00046	0.00481	CcSEcCtD
Zafirlukast—Nausea—Lomustine—brain cancer	0.000448	0.00468	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—PTCH2—brain cancer	0.000445	0.00881	CbGpPWpGaD
Zafirlukast—Neuropathy peripheral—Temozolomide—brain cancer	0.000445	0.00465	CcSEcCtD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—TRPC6—brain cancer	0.000438	0.00868	CbGpPWpGaD
Zafirlukast—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000436	0.00456	CcSEcCtD
Zafirlukast—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000434	0.00859	CbGpPWpGaD
Zafirlukast—Insomnia—Procarbazine—brain cancer	0.000433	0.00453	CcSEcCtD
Zafirlukast—Sinusitis—Temozolomide—brain cancer	0.000426	0.00445	CcSEcCtD
Zafirlukast—Haemoglobin—Carmustine—brain cancer	0.000424	0.00443	CcSEcCtD
Zafirlukast—Haemorrhage—Carmustine—brain cancer	0.000422	0.00441	CcSEcCtD
Zafirlukast—Ill-defined disorder—Hydroxyurea—brain cancer	0.000421	0.00441	CcSEcCtD
Zafirlukast—Hypoaesthesia—Carmustine—brain cancer	0.000419	0.00439	CcSEcCtD
Zafirlukast—Fatigue—Procarbazine—brain cancer	0.000413	0.00432	CcSEcCtD
Zafirlukast—Haemoglobin—Temozolomide—brain cancer	0.000409	0.00428	CcSEcCtD
Zafirlukast—Malaise—Hydroxyurea—brain cancer	0.000409	0.00428	CcSEcCtD
Zafirlukast—Pain—Procarbazine—brain cancer	0.000409	0.00428	CcSEcCtD
Zafirlukast—Haemorrhage—Temozolomide—brain cancer	0.000407	0.00426	CcSEcCtD
Zafirlukast—Hepatitis—Temozolomide—brain cancer	0.000407	0.00426	CcSEcCtD
Zafirlukast—Hypoaesthesia—Temozolomide—brain cancer	0.000405	0.00424	CcSEcCtD
Zafirlukast—ABCG2—Irinotecan Pathway—APC—brain cancer	0.000402	0.00797	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Procarbazine—brain cancer	0.000394	0.00413	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000392	0.00776	CbGpPWpGaD
Zafirlukast—Gastrointestinal pain—Procarbazine—brain cancer	0.000391	0.00409	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—OR14C36—brain cancer	0.00039	0.00773	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—OR4C12—brain cancer	0.00039	0.00773	CbGpPWpGaD
Zafirlukast—Discomfort—Hydroxyurea—brain cancer	0.000382	0.00399	CcSEcCtD
Zafirlukast—Neutropenia—Etoposide—brain cancer	0.000381	0.00398	CcSEcCtD
Zafirlukast—Urticaria—Procarbazine—brain cancer	0.00038	0.00398	CcSEcCtD
Zafirlukast—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00038	0.00752	CbGpPWpGaD
Zafirlukast—Body temperature increased—Procarbazine—brain cancer	0.000378	0.00396	CcSEcCtD
Zafirlukast—Abdominal pain—Procarbazine—brain cancer	0.000378	0.00396	CcSEcCtD
Zafirlukast—Oedema—Hydroxyurea—brain cancer	0.00037	0.00388	CcSEcCtD
Zafirlukast—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000369	0.0073	CbGpPWpGaD
Zafirlukast—Infection—Hydroxyurea—brain cancer	0.000368	0.00385	CcSEcCtD
Zafirlukast—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000365	0.00723	CbGpPWpGaD
Zafirlukast—Thrombocytopenia—Hydroxyurea—brain cancer	0.000363	0.00379	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Etoposide—brain cancer	0.000356	0.00372	CcSEcCtD
Zafirlukast—Back pain—Carmustine—brain cancer	0.000355	0.00371	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—OR14C36—brain cancer	0.000354	0.00702	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—OR4C12—brain cancer	0.000354	0.00702	CbGpPWpGaD
Zafirlukast—Jaundice—Etoposide—brain cancer	0.000354	0.0037	CcSEcCtD
Zafirlukast—Hypersensitivity—Procarbazine—brain cancer	0.000353	0.00369	CcSEcCtD
Zafirlukast—Asthenia—Procarbazine—brain cancer	0.000343	0.00359	CcSEcCtD
Zafirlukast—Back pain—Temozolomide—brain cancer	0.000343	0.00359	CcSEcCtD
Zafirlukast—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00034	0.00673	CbGpPWpGaD
Zafirlukast—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00034	0.00673	CbGpPWpGaD
Zafirlukast—Agranulocytosis—Etoposide—brain cancer	0.000339	0.00354	CcSEcCtD
Zafirlukast—Pruritus—Procarbazine—brain cancer	0.000339	0.00354	CcSEcCtD
Zafirlukast—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000335	0.00664	CbGpPWpGaD
Zafirlukast—Ill-defined disorder—Temozolomide—brain cancer	0.000329	0.00344	CcSEcCtD
Zafirlukast—Diarrhoea—Procarbazine—brain cancer	0.000328	0.00343	CcSEcCtD
Zafirlukast—Dyspepsia—Hydroxyurea—brain cancer	0.000326	0.00341	CcSEcCtD
Zafirlukast—Hypoaesthesia—Etoposide—brain cancer	0.000324	0.00339	CcSEcCtD
Zafirlukast—Angioedema—Temozolomide—brain cancer	0.000324	0.00339	CcSEcCtD
Zafirlukast—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000322	0.00638	CbGpPWpGaD
Zafirlukast—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00032	0.00335	CcSEcCtD
Zafirlukast—Malaise—Temozolomide—brain cancer	0.00032	0.00334	CcSEcCtD
Zafirlukast—Fatigue—Hydroxyurea—brain cancer	0.000319	0.00334	CcSEcCtD
Zafirlukast—Pain—Hydroxyurea—brain cancer	0.000317	0.00331	CcSEcCtD
Zafirlukast—Dizziness—Procarbazine—brain cancer	0.000317	0.00331	CcSEcCtD
Zafirlukast—Myalgia—Carmustine—brain cancer	0.000312	0.00327	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—PTCH2—brain cancer	0.000308	0.00611	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Hydroxyurea—brain cancer	0.000305	0.00319	CcSEcCtD
Zafirlukast—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000305	0.00604	CbGpPWpGaD
Zafirlukast—Vomiting—Procarbazine—brain cancer	0.000304	0.00318	CcSEcCtD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—TRPC6—brain cancer	0.000304	0.00602	CbGpPWpGaD
Zafirlukast—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000303	0.00601	CbGpPWpGaD
Zafirlukast—Arthralgia—Temozolomide—brain cancer	0.000302	0.00316	CcSEcCtD
Zafirlukast—Myalgia—Temozolomide—brain cancer	0.000302	0.00316	CcSEcCtD
Zafirlukast—Rash—Procarbazine—brain cancer	0.000302	0.00316	CcSEcCtD
Zafirlukast—Dermatitis—Procarbazine—brain cancer	0.000302	0.00315	CcSEcCtD
Zafirlukast—Headache—Procarbazine—brain cancer	0.0003	0.00314	CcSEcCtD
Zafirlukast—Oedema—Carmustine—brain cancer	0.000299	0.00313	CcSEcCtD
Zafirlukast—Discomfort—Temozolomide—brain cancer	0.000298	0.00312	CcSEcCtD
Zafirlukast—Infection—Carmustine—brain cancer	0.000298	0.00311	CcSEcCtD
Zafirlukast—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000294	0.00582	CbGpPWpGaD
Zafirlukast—Thrombocytopenia—Carmustine—brain cancer	0.000293	0.00307	CcSEcCtD
Zafirlukast—Body temperature increased—Hydroxyurea—brain cancer	0.000293	0.00306	CcSEcCtD
Zafirlukast—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00029	0.00574	CbGpPWpGaD
Zafirlukast—Oedema—Temozolomide—brain cancer	0.000289	0.00303	CcSEcCtD
Zafirlukast—Infection—Temozolomide—brain cancer	0.000288	0.00301	CcSEcCtD
Zafirlukast—Nausea—Procarbazine—brain cancer	0.000284	0.00297	CcSEcCtD
Zafirlukast—Thrombocytopenia—Temozolomide—brain cancer	0.000283	0.00296	CcSEcCtD
Zafirlukast—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000278	0.0055	CbGpPWpGaD
Zafirlukast—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000276	0.00546	CbGpPWpGaD
Zafirlukast—Back pain—Etoposide—brain cancer	0.000274	0.00287	CcSEcCtD
Zafirlukast—Hypersensitivity—Hydroxyurea—brain cancer	0.000273	0.00285	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Carmustine—brain cancer	0.000273	0.00285	CcSEcCtD
Zafirlukast—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000272	0.00539	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000272	0.00538	CbGpPWpGaD
Zafirlukast—Insomnia—Carmustine—brain cancer	0.000271	0.00283	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR downstream signaling—OR14C36—brain cancer	0.000271	0.00536	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—OR4C12—brain cancer	0.000271	0.00536	CbGpPWpGaD
Zafirlukast—Asthenia—Hydroxyurea—brain cancer	0.000266	0.00278	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000264	0.00276	CcSEcCtD
Zafirlukast—Ill-defined disorder—Etoposide—brain cancer	0.000263	0.00275	CcSEcCtD
Zafirlukast—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000262	0.00519	CbGpPWpGaD
Zafirlukast—Insomnia—Temozolomide—brain cancer	0.000262	0.00274	CcSEcCtD
Zafirlukast—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000261	0.00517	CbGpPWpGaD
Zafirlukast—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000259	0.00513	CbGpPWpGaD
Zafirlukast—Gastrointestinal disorder—Carmustine—brain cancer	0.000259	0.0027	CcSEcCtD
Zafirlukast—Pain—Carmustine—brain cancer	0.000256	0.00268	CcSEcCtD
Zafirlukast—Malaise—Etoposide—brain cancer	0.000256	0.00268	CcSEcCtD
Zafirlukast—Dyspepsia—Temozolomide—brain cancer	0.000255	0.00266	CcSEcCtD
Zafirlukast—Diarrhoea—Hydroxyurea—brain cancer	0.000253	0.00265	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Temozolomide—brain cancer	0.00025	0.00261	CcSEcCtD
Zafirlukast—Fatigue—Temozolomide—brain cancer	0.00025	0.00261	CcSEcCtD
Zafirlukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000248	0.00492	CbGpPWpGaD
Zafirlukast—Pain—Temozolomide—brain cancer	0.000247	0.00259	CcSEcCtD
Zafirlukast—Feeling abnormal—Carmustine—brain cancer	0.000247	0.00258	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—OR4C12—brain cancer	0.000246	0.00487	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—OR14C36—brain cancer	0.000246	0.00487	CbGpPWpGaD
Zafirlukast—Dizziness—Hydroxyurea—brain cancer	0.000245	0.00256	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Carmustine—brain cancer	0.000245	0.00256	CcSEcCtD
Zafirlukast—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000241	0.00478	CbGpPWpGaD
Zafirlukast—Discomfort—Etoposide—brain cancer	0.000239	0.0025	CcSEcCtD
Zafirlukast—Feeling abnormal—Temozolomide—brain cancer	0.000238	0.00249	CcSEcCtD
Zafirlukast—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000238	0.00472	CbGpPWpGaD
Zafirlukast—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000238	0.00472	CbGpPWpGaD
Zafirlukast—Body temperature increased—Carmustine—brain cancer	0.000237	0.00248	CcSEcCtD
Zafirlukast—Abdominal pain—Carmustine—brain cancer	0.000237	0.00248	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Temozolomide—brain cancer	0.000237	0.00248	CcSEcCtD
Zafirlukast—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000236	0.00468	CbGpPWpGaD
Zafirlukast—Vomiting—Hydroxyurea—brain cancer	0.000236	0.00246	CcSEcCtD
Zafirlukast—Rash—Hydroxyurea—brain cancer	0.000234	0.00244	CcSEcCtD
Zafirlukast—Dermatitis—Hydroxyurea—brain cancer	0.000233	0.00244	CcSEcCtD
Zafirlukast—Headache—Hydroxyurea—brain cancer	0.000232	0.00243	CcSEcCtD
Zafirlukast—Infection—Etoposide—brain cancer	0.00023	0.00241	CcSEcCtD
Zafirlukast—Urticaria—Temozolomide—brain cancer	0.00023	0.0024	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—SHH—brain cancer	0.000229	0.00454	CbGpPWpGaD
Zafirlukast—Abdominal pain—Temozolomide—brain cancer	0.000229	0.00239	CcSEcCtD
Zafirlukast—Body temperature increased—Temozolomide—brain cancer	0.000229	0.00239	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—PTCH2—brain cancer	0.000228	0.00452	CbGpPWpGaD
Zafirlukast—Thrombocytopenia—Etoposide—brain cancer	0.000227	0.00237	CcSEcCtD
Zafirlukast—Hypersensitivity—Carmustine—brain cancer	0.000221	0.00231	CcSEcCtD
Zafirlukast—Nausea—Hydroxyurea—brain cancer	0.00022	0.0023	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—PTCH1—brain cancer	0.000217	0.0043	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—SMO—brain cancer	0.000217	0.0043	CbGpPWpGaD
Zafirlukast—Asthenia—Carmustine—brain cancer	0.000215	0.00225	CcSEcCtD
Zafirlukast—Hypersensitivity—Temozolomide—brain cancer	0.000213	0.00223	CcSEcCtD
Zafirlukast—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000213	0.00421	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—OR4C12—brain cancer	0.000209	0.00415	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—OR14C36—brain cancer	0.000209	0.00415	CbGpPWpGaD
Zafirlukast—Asthenia—Temozolomide—brain cancer	0.000208	0.00217	CcSEcCtD
Zafirlukast—Diarrhoea—Carmustine—brain cancer	0.000205	0.00214	CcSEcCtD
Zafirlukast—Pruritus—Temozolomide—brain cancer	0.000205	0.00214	CcSEcCtD
Zafirlukast—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000204	0.00405	CbGpPWpGaD
Zafirlukast—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000202	0.00399	CbGpPWpGaD
Zafirlukast—Gastrointestinal disorder—Etoposide—brain cancer	0.0002	0.00209	CcSEcCtD
Zafirlukast—Fatigue—Etoposide—brain cancer	0.0002	0.00209	CcSEcCtD
Zafirlukast—Dizziness—Carmustine—brain cancer	0.000198	0.00207	CcSEcCtD
Zafirlukast—Pain—Etoposide—brain cancer	0.000198	0.00207	CcSEcCtD
Zafirlukast—Diarrhoea—Temozolomide—brain cancer	0.000198	0.00207	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—ABR—brain cancer	0.000197	0.00391	CbGpPWpGaD
Zafirlukast—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000196	0.00388	CbGpPWpGaD
Zafirlukast—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000196	0.00387	CbGpPWpGaD
Zafirlukast—Dizziness—Temozolomide—brain cancer	0.000191	0.002	CcSEcCtD
Zafirlukast—Feeling abnormal—Etoposide—brain cancer	0.000191	0.002	CcSEcCtD
Zafirlukast—Vomiting—Carmustine—brain cancer	0.00019	0.00199	CcSEcCtD
Zafirlukast—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.00019	0.00377	CbGpPWpGaD
Zafirlukast—Gastrointestinal pain—Etoposide—brain cancer	0.000189	0.00198	CcSEcCtD
Zafirlukast—Rash—Carmustine—brain cancer	0.000189	0.00198	CcSEcCtD
Zafirlukast—Dermatitis—Carmustine—brain cancer	0.000189	0.00197	CcSEcCtD
Zafirlukast—Headache—Carmustine—brain cancer	0.000188	0.00196	CcSEcCtD
Zafirlukast—Vomiting—Temozolomide—brain cancer	0.000184	0.00192	CcSEcCtD
Zafirlukast—Urticaria—Etoposide—brain cancer	0.000184	0.00192	CcSEcCtD
Zafirlukast—Body temperature increased—Etoposide—brain cancer	0.000183	0.00191	CcSEcCtD
Zafirlukast—Abdominal pain—Etoposide—brain cancer	0.000183	0.00191	CcSEcCtD
Zafirlukast—Rash—Temozolomide—brain cancer	0.000182	0.00191	CcSEcCtD
Zafirlukast—Dermatitis—Temozolomide—brain cancer	0.000182	0.00191	CcSEcCtD
Zafirlukast—Headache—Temozolomide—brain cancer	0.000181	0.0019	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—ABR—brain cancer	0.000179	0.00355	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—DTX2—brain cancer	0.000178	0.00353	CbGpPWpGaD
Zafirlukast—Nausea—Carmustine—brain cancer	0.000178	0.00186	CcSEcCtD
Zafirlukast—Nausea—Temozolomide—brain cancer	0.000172	0.0018	CcSEcCtD
Zafirlukast—Hypersensitivity—Etoposide—brain cancer	0.000171	0.00178	CcSEcCtD
Zafirlukast—Asthenia—Etoposide—brain cancer	0.000166	0.00174	CcSEcCtD
Zafirlukast—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000166	0.00328	CbGpPWpGaD
Zafirlukast—Pruritus—Etoposide—brain cancer	0.000164	0.00171	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—SHH—brain cancer	0.000159	0.00315	CbGpPWpGaD
Zafirlukast—Diarrhoea—Etoposide—brain cancer	0.000158	0.00166	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—PTCH2—brain cancer	0.000158	0.00314	CbGpPWpGaD
Zafirlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000158	0.00312	CbGpPWpGaD
Zafirlukast—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000156	0.00308	CbGpPWpGaD
Zafirlukast—Dizziness—Etoposide—brain cancer	0.000153	0.0016	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—SMO—brain cancer	0.000151	0.00298	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—PTCH1—brain cancer	0.000151	0.00298	CbGpPWpGaD
Zafirlukast—Vomiting—Etoposide—brain cancer	0.000147	0.00154	CcSEcCtD
Zafirlukast—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000146	0.0029	CbGpPWpGaD
Zafirlukast—Rash—Etoposide—brain cancer	0.000146	0.00153	CcSEcCtD
Zafirlukast—Dermatitis—Etoposide—brain cancer	0.000146	0.00153	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling Pathways—OR14C36—brain cancer	0.000145	0.00287	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—OR4C12—brain cancer	0.000145	0.00287	CbGpPWpGaD
Zafirlukast—Headache—Etoposide—brain cancer	0.000145	0.00152	CcSEcCtD
Zafirlukast—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000144	0.00286	CbGpPWpGaD
Zafirlukast—Nausea—Etoposide—brain cancer	0.000138	0.00144	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR downstream signaling—ABR—brain cancer	0.000137	0.00271	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTCH2—brain cancer	0.000135	0.00267	CbGpPWpGaD
Zafirlukast—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000134	0.00265	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HES5—brain cancer	0.000131	0.00259	CbGpPWpGaD
Zafirlukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000128	0.00253	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—STRADA—brain cancer	0.000127	0.00251	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000127	0.00251	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—TRPC6—brain cancer	0.000125	0.00247	CbGpPWpGaD
Zafirlukast—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000125	0.00247	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—ABR—brain cancer	0.000124	0.00246	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—DTX2—brain cancer	0.000123	0.00244	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.00012	0.00238	CbGpPWpGaD
Zafirlukast—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000119	0.00235	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	0.000118	0.00234	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—SHH—brain cancer	0.000118	0.00233	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—TRPC6—brain cancer	0.000113	0.00225	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000113	0.00224	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—SMO—brain cancer	0.000112	0.00221	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—PTCH1—brain cancer	0.000112	0.00221	CbGpPWpGaD
Zafirlukast—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000111	0.00221	CbGpPWpGaD
Zafirlukast—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000109	0.00216	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ABR—brain cancer	0.000106	0.0021	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000104	0.00206	CbGpPWpGaD
Zafirlukast—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000102	0.00203	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—GLI2—brain cancer	0.000102	0.00203	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.0001	0.00199	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—GLI1—brain cancer	9.61e-05	0.0019	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—VAV1—brain cancer	9.36e-05	0.00185	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTCH2—brain cancer	9.35e-05	0.00185	CbGpPWpGaD
Zafirlukast—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	9.15e-05	0.00181	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SUFU—brain cancer	9.11e-05	0.0018	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	9.08e-05	0.0018	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HES5—brain cancer	9.06e-05	0.00179	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	8.98e-05	0.00178	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—CYP2C9—brain cancer	8.8e-05	0.00174	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—GFAP—brain cancer	8.79e-05	0.00174	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—STRADA—brain cancer	8.79e-05	0.00174	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	8.68e-05	0.00172	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—TRPC6—brain cancer	8.66e-05	0.00172	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—VAV1—brain cancer	8.5e-05	0.00168	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HEY1—brain cancer	8.34e-05	0.00165	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—DLL1—brain cancer	8.17e-05	0.00162	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—SHH—brain cancer	8.16e-05	0.00162	CbGpPWpGaD
Zafirlukast—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	8.12e-05	0.00161	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—TRPC6—brain cancer	7.86e-05	0.00156	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PTCH1—brain cancer	7.73e-05	0.00153	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—SMO—brain cancer	7.73e-05	0.00153	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.52e-05	0.00149	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ABR—brain cancer	7.34e-05	0.00145	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—GLI2—brain cancer	7.09e-05	0.0014	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	6.96e-05	0.00138	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	6.96e-05	0.00138	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SHH—brain cancer	6.95e-05	0.00138	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	6.94e-05	0.00137	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.79e-05	0.00135	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TRPC6—brain cancer	6.7e-05	0.00133	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.7e-05	0.00133	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—GLI1—brain cancer	6.66e-05	0.00132	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SMO—brain cancer	6.59e-05	0.0013	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTCH1—brain cancer	6.59e-05	0.0013	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—VAV1—brain cancer	6.49e-05	0.00129	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SUFU—brain cancer	6.32e-05	0.00125	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—GFAP—brain cancer	6.09e-05	0.00121	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—PIK3CG—brain cancer	5.94e-05	0.00118	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—VAV1—brain cancer	5.89e-05	0.00117	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HEY1—brain cancer	5.78e-05	0.00114	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—DLL1—brain cancer	5.67e-05	0.00112	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.5e-05	0.00109	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—PIK3CG—brain cancer	5.4e-05	0.00107	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NOTCH2—brain cancer	5.27e-05	0.00104	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.24e-05	0.00104	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—VAV1—brain cancer	5.02e-05	0.000995	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.86e-05	0.000962	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SHH—brain cancer	4.82e-05	0.000954	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.72e-05	0.000934	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TRPC6—brain cancer	4.65e-05	0.00092	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTCH1—brain cancer	4.57e-05	0.000905	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SMO—brain cancer	4.57e-05	0.000905	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.34e-05	0.000859	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HES1—brain cancer	4.32e-05	0.000855	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—IL2—brain cancer	4.18e-05	0.000828	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.15e-05	0.000822	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—PIK3CG—brain cancer	4.12e-05	0.000816	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PDGFRA—brain cancer	4.11e-05	0.000814	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.01e-05	0.000794	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SPP1—brain cancer	3.99e-05	0.000791	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL2—brain cancer	3.8e-05	0.000752	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PIK3CG—brain cancer	3.74e-05	0.000741	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.69e-05	0.00073	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NOTCH2—brain cancer	3.65e-05	0.000723	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IRS2—brain cancer	3.61e-05	0.000715	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.61e-05	0.000714	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.61e-05	0.000714	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.55e-05	0.000704	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP2C9—brain cancer	3.49e-05	0.000691	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VAV1—brain cancer	3.48e-05	0.000689	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.38e-05	0.000669	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP2C9—brain cancer	3.35e-05	0.000664	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—APC—brain cancer	3.19e-05	0.000631	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PIK3CG—brain cancer	3.19e-05	0.000631	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.17e-05	0.000628	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HES1—brain cancer	2.99e-05	0.000593	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—BSG—brain cancer	2.96e-05	0.000587	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—EGFR—brain cancer	2.9e-05	0.000575	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—IL2—brain cancer	2.9e-05	0.000574	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.89e-05	0.000573	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PDGFRA—brain cancer	2.85e-05	0.000565	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—BSG—brain cancer	2.85e-05	0.000564	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SPP1—brain cancer	2.77e-05	0.000548	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL2—brain cancer	2.63e-05	0.000521	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—IDH1—brain cancer	2.55e-05	0.000505	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP2C9—brain cancer	2.5e-05	0.000496	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IRS2—brain cancer	2.5e-05	0.000496	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—RELA—brain cancer	2.49e-05	0.000493	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ERBB2—brain cancer	2.48e-05	0.00049	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.47e-05	0.000489	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—IDH1—brain cancer	2.45e-05	0.000485	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL2—brain cancer	2.24e-05	0.000444	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—APC—brain cancer	2.21e-05	0.000438	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CG—brain cancer	2.21e-05	0.000438	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCND1—brain cancer	2.19e-05	0.000433	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CTNNB1—brain cancer	2.17e-05	0.000429	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP2C9—brain cancer	2.16e-05	0.000429	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—BSG—brain cancer	2.13e-05	0.000422	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ENO2—brain cancer	2.02e-05	0.000399	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—EGFR—brain cancer	2.01e-05	0.000399	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.99e-05	0.000395	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ENO2—brain cancer	1.94e-05	0.000383	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP2C9—brain cancer	1.93e-05	0.000383	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—VEGFA—brain cancer	1.91e-05	0.000378	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—STAT3—brain cancer	1.89e-05	0.000374	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—BSG—brain cancer	1.84e-05	0.000364	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—IDH1—brain cancer	1.83e-05	0.000363	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP2C9—brain cancer	1.78e-05	0.000352	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MYC—brain cancer	1.75e-05	0.000347	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RELA—brain cancer	1.73e-05	0.000342	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EGFR—brain cancer	1.72e-05	0.00034	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ERBB2—brain cancer	1.72e-05	0.00034	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—BSG—brain cancer	1.64e-05	0.000325	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—IDH1—brain cancer	1.58e-05	0.000313	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL2—brain cancer	1.56e-05	0.000308	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCND1—brain cancer	1.52e-05	0.0003	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—BSG—brain cancer	1.51e-05	0.000299	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP2C9—brain cancer	1.5e-05	0.000298	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CTNNB1—brain cancer	1.5e-05	0.000297	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—BSG—brain cancer	1.5e-05	0.000297	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ENO2—brain cancer	1.45e-05	0.000287	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—brain cancer	1.44e-05	0.000285	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—IDH1—brain cancer	1.41e-05	0.00028	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VEGFA—brain cancer	1.32e-05	0.000262	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—STAT3—brain cancer	1.31e-05	0.000259	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—IDH1—brain cancer	1.3e-05	0.000257	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.29e-05	0.000255	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—IDH1—brain cancer	1.29e-05	0.000255	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—BSG—brain cancer	1.28e-05	0.000253	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ENO2—brain cancer	1.25e-05	0.000248	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MYC—brain cancer	1.22e-05	0.000241	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EGFR—brain cancer	1.19e-05	0.000236	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP2C9—brain cancer	1.16e-05	0.00023	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.15e-05	0.000228	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ENO2—brain cancer	1.12e-05	0.000221	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—IDH1—brain cancer	1.1e-05	0.000218	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.05e-05	0.000208	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ENO2—brain cancer	1.03e-05	0.000203	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ENO2—brain cancer	1.02e-05	0.000202	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—brain cancer	9.99e-06	0.000198	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—BSG—brain cancer	9.88e-06	0.000196	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CG—brain cancer	9.25e-06	0.000183	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.96e-06	0.000177	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CG—brain cancer	8.88e-06	0.000176	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ENO2—brain cancer	8.7e-06	0.000172	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—IDH1—brain cancer	8.49e-06	0.000168	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ENO2—brain cancer	6.71e-06	0.000133	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CG—brain cancer	6.64e-06	0.000131	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CG—brain cancer	5.74e-06	0.000114	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CG—brain cancer	5.12e-06	0.000101	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CG—brain cancer	4.71e-06	9.33e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CG—brain cancer	4.67e-06	9.25e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CG—brain cancer	3.99e-06	7.9e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CG—brain cancer	3.08e-06	6.1e-05	CbGpPWpGaD
